Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer.
about
Management of colorectal cancerPrognostic and predictive markers in stage II colon cancer: is there a role for gene expression profiling?Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?Analysis of post-operative changes in serum protein expression profiles from colorectal cancer patients by MALDI-TOF mass spectrometry: a pilot methodological studyDefective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.Consensus pathways implicated in prognosis of colorectal cancer identified through systematic enrichment analysis of gene expression profiling studiesClinical value of prognosis gene expression signatures in colorectal cancer: a systematic review.Comparison of prognostic genomic predictors in colorectal cancer.Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factorsA Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome.Next generation sequencing and a new era of medicine.Biomarkers in precision therapy in colorectal cancer.Recent approaches to identifying biomarkers for high-risk stage II colon cancer.Biomarkers in early-stage colorectal cancer: ready for prime time?Current and future biomarkers in the treatment of colorectal cancer.Colon cancer subtypes: concordance, effect on survival and selection of the most representative preclinical models.Evaluation of frozen tissue-derived prognostic gene expression signatures in FFPE colorectal cancer samples.Mutant-Allele Tumor Heterogeneity Scores Correlate With Risk of Metastases in Colon Cancer.Intra-tumoural stromal morphometry predicts disease recurrence but not response to 5-fluorouracil - results from the QUASAR trial of colorectal cancer.Predictive and prognostic roles of ribonucleotide reductase M1 in resectable pancreatic adenocarcinoma.Classification of large microarray datasets using fast random forest construction.Re: test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.Prognostic roles of human equilibrative transporter 1 (hENT-1) and ribonucleoside reductase subunit M1 (RRM1) in resected pancreatic cancer.Are Gene Signatures Ready for Use in the Selection of Patients for Adjuvant Treatment?Clinicopathological risk factors of Stage II colon cancer: results of a prospective study
P2860
Q26823550-193537FB-643F-4790-AE97-E0FD06126DE5Q26830362-0AF8BE3A-F8B2-409C-8742-45C1EE370339Q30854540-7BBAA36D-DB15-4CF2-A8B1-7D37D5726C9FQ30856729-870FC9BB-5576-45C4-BE9F-65CDF135E65EQ33564901-FAC91AC3-2659-45D4-8201-415FA795DC1AQ33586020-467603E8-9ABA-4BC0-90A1-0187D4498550Q33889157-47DA9097-377A-413D-9DCF-AC4CDFBB3313Q34473636-C573FAAD-A3BF-4709-9E4E-FE23A53788D9Q34692073-D72C633A-16DD-45F1-900F-3B2B648ABA7BQ35057318-10ECF5B9-5540-4FCE-BA5C-C6A5D7D7544AQ36714160-B36F4935-C0B5-4705-BB7B-2D643B206318Q37409165-1066EBE3-A8D5-43B0-A813-9DF5619B5542Q37609130-6C117864-F79F-45FF-A6BB-B9F82D4E55CCQ38041974-B9556A20-0AAB-42FE-802C-63635FA7BBB7Q38064740-E431F83C-5B72-40B9-9773-63B75050CC80Q38787244-5FD4972E-85B8-4BC2-8CAD-21B848EB54D2Q39184305-0BB3E8A7-4C46-40DC-94AB-A169AAE26534Q39395473-A4E13B73-EA26-432D-AA43-3D4701A09C58Q40386896-5496425F-94DB-4D80-8C98-E7B1FC3D3B9DQ40489826-14792B7E-97E6-4329-952E-4E10A8C41F9CQ43829586-9BFC3046-CA5A-4AF5-81EC-3EA3DB79CA8BQ45961973-6528D95C-09BD-43F0-B389-061146964368Q53588319-863D4B15-EFBE-43EC-BF24-C9A0FF8C66A0Q54391141-14C2ED9D-7E29-4C5E-8C19-F763765BD15EQ58053523-363A7C2B-64B1-4464-93BC-7AE173D93699Q58053589-91632D62-5BB6-404C-B399-3F43A1450866
P2860
Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Development of a clinically fe ...... ence of stage II colon cancer.
@ast
Development of a clinically fe ...... ence of stage II colon cancer.
@en
type
label
Development of a clinically fe ...... ence of stage II colon cancer.
@ast
Development of a clinically fe ...... ence of stage II colon cancer.
@en
prefLabel
Development of a clinically fe ...... ence of stage II colon cancer.
@ast
Development of a clinically fe ...... ence of stage II colon cancer.
@en
P2093
P2860
P1476
Development of a clinically fe ...... ence of stage II colon cancer.
@en
P2093
Abhijit Mazumder
Conor P Delaney
David Atkins
Dmitri Talantov
Elena Manilich
Graham Casey
Ian C Lavery
Marek Skacel
Michelle Martin-McGreevy
P2860
P304
P356
10.2353/JMOLDX.2008.080011
P577
2008-06-13T00:00:00Z